Search results | manufacturing


Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics

The Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the manufacturing and supply agreements entered into by the worlds leading biopharma companies.


Manufacturing and Supply partnering: global trends in pharma industry

The article here analyses the recent manufacturing and supply partnering trends in the pharma industry. A supply or manufacturing agreement is normally between a product manufacturer and product owner in which an owner outsources the manufacture and supply of its product(s) to the service company in a defined territory.


Manufacturing is the production of goods for use or sale using labor and machines, tools, chemical..

Biotech rumour mill:Lilly to add $180 million insulin manufacturing operation

Biotech rumour mill: Eli Lilly, a big pharma company, rumours to invest an additional $180 million in the company’s Indianapolis-based insulin manufacturing operations.

Manufacturing and supply agreements: recent life sciences partnering deal trends

Manufacturing and supply agreements have long been present in the pharmaceutical industry, as companies have sought external expertise for manufacturing and supply of finished product.

Sanofi set to open largest manufacturing unit in India

French pharmaceutical company Sanofi Pasteur, which acquired City-based Shantha Biotechnics for Rs 3,000 crore in 2009, will soon unveil its largest manufacturing asset here

Recent Trends in Manufacturing Deals & Alliances

An article written by Steve Poile on biopharma manufacturing alliances. 

More merger talks for Claris Lifesciences: Pfizer, Amneal, Novartis…

India-based CLARIS Lifesciences Ltd., which operates a generic sterile injectables business, has become the belle of the ball as multi-national companies such as Pfizer Inc., Amneal, Novartis AG and Indian companies such as Lupin and Cipla, are lining up to play the

Aspen Pharma: Partnering activity 2009-2014

Aspen Pharma, a global branded and generics pharmaceutical manufacturer, has found a place in the top 50 big pharma companies listed by Current Partnering.

Aspen Pharmacare – Africa’s biggest generic drugmaker

Aspen Pharmacare specialises in the production of branded and generic pharmaceuticals and is currently the biggest pharmaceutical company in South Africa taking a 15% share of the total market.

Current Agreements Deal Analysis Update : November 2014

This month we provide you with an overview of deal analysis in the life science sectors, covering partnering, M&A and financing in October 2014.


Development agreement for human regenerative therapy with induced pluripotent stem cells

Catalent Pharma Solutions announced an agreement with the Center for iPS Cell Research and Application at Kyoto University in Japan to make a major advancement toward one of the first regenerative human therapies with induced pluripotent stem (iPS) cells applicable to humans.


Bayer and Aronora in AB-022 manufacturing pact

Bayer HealthCare and Aronora announced its strategic alliance to manufacture Aronora’s AB-022 compound for the treatment of cardiovascular diseases

Sanofi and Boehringer Ingelheim in antibody manufacturing pact

Boehringer Ingelheim and Sanofi enter into an alliance to extend Sanofi’s manufacturing capacity network for therapeutic monoclonal antibodies

Manufacturing agreement for biologics between Bristol-Myers Squibb and Lonza

Bristol-Myers Squibb Company and Lonza announced a multi-year expansion of their existing biologics manufacturing agreement.

Development and manufacturing agreement for mAb TMB-360

EirGenix has signed the agreement with TaiMed Biologics to provide development and manufacturing services for TaiMed’s second generation anti-HIV monoclonal antibody, TMB-360.

Manufacturing and supply agreement for gene expression assays

HTG Molecular Diagnostics and OvaGene Oncology have entered a manufacturing supply agreement where OvaGene will design and develop their proprietary gene expression assays on HTG’s fully automated, extraction-free Edge Platform.

Hospira in pharma partnering with Orchid to acquire its API manufacturing & R&D facilities

Hospira, a big pharma company singed a definitive pharma partnering agreement to acquire an active pharmaceutical ingredient (API) manufacturing facility, together with an associated research and development (R&D) facility, from Orchid Chemicals & Pharmaceuticals for approximately $200 million.

Collaborative R&D and manufacturing pharma partnering agreement for Adcretis

Seattle Genetics and Millennium have formed a pharma partnering collaboration with Ventana Medical Systems

Roche signs manufacturing contract with Emcure for blockbuster biologics drugs

Roche has made a shift in its strategy by signing a manufacturing contract with Emcure Pharma for its blockbuster biologics drugs Herceptin and MabThera. 

Abbott and Thermo Fisher Scientific in PCT assay manufacturing and distribution pact

Thermo Fisher Scientific announced an agreement with global healthcare provider Abbott Laboratories to make its Procalcitonin (PCT) assay available with Abbott’s immunochemistry analyzers

MorphoSys signs manufacturing agreement with Boehringer

MorphoSys AG and Boehringer Ingelheim have announced the signing of a biopharmaceutical manufacturing agreement for therapeutic antibodies.